In response to tumor-derived factors (TGF-β, LPA, IL-1, IL-6) or tumor-derived exosomes, which activate the SMAD, JAK-STAT and NF-κB pathways, fibroblasts become activated. The gene discussed is TGFB1; the disease is neoplasm.